» Articles » PMID: 20127241

Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: a Lesson from 229 Consecutive Cases of Curative Liver Resection

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2010 Feb 4
PMID 20127241
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Microscopic vascular invasion is an important risk factor for recurrent hepatocellular carcinoma (HCC), even after curative liver resection or orthotopic liver transplantation. To predict microscopic portal venous invasion, the following two questions were examined retrospectively: Is it possible to detect microvascular invasion preoperatively? What are the characteristics of a group of early HCC recurrences even with no microvascular invasion?

Methods: Study 1 included 229 patients with HCC who underwent curative liver resection between 1991 and 2008; 127 had HCC without microscopic portal venous invasion, and 52 had HCC with microscopic portal venous invasion (MPVI). These two distinct groups were analyzed with regard to various clinicopathologic factors. Subsequently, we specifically investigated if HCCs <5 cm with vascular invasion (n = 32) have some characteristics that would allow detection of latent microvascular invasion. Study 2 included 127 HCC patients without MVPI; 42 had a recurrence within 2 years, and 85 patients were recurrence-free for at least 2 years. These two distinct groups were analyzed with regard to various clinicopathologic factors.

Results: HCC diameter of >5 cm, the macroscopic appearance of HCC, and high levels of preoperative des-gamma-carboxyprothrombin are significant prognostic factors in identifying microvascular invasion of HCC. The strongest predictor of early recurrence (within 2 years) was the serum alpha-fetoprotein level in patients without clear microvascular invasion.

Conclusions: Tumor size, macroscopic appearance, and high tumor marker levels are important elements in identifying the group of patients with a low HCC recurrence rate after curative liver resection.

Citing Articles

Development and validation of a digital biopsy model to predict microvascular invasion in hepatocellular carcinoma.

Birgin E, Nebelung H, Abdelhadi S, Rink J, Froelich M, Hetjens S Front Oncol. 2024; 14:1360936.

PMID: 39376989 PMC: 11457731. DOI: 10.3389/fonc.2024.1360936.


Development of a Better Nomogram for Prediction of Preoperative Microvascular Invasion and Postoperative Prognosis in Hepatocellular Carcinoma Patients: A Comparison Study.

Pei J, Wang L, Li H J Comput Assist Tomogr. 2024; 49(1):9-22.

PMID: 38663025 PMC: 11801467. DOI: 10.1097/RCT.0000000000001618.


The influencing factors for tumor thrombus in patients with hepatocellular carcinoma.

Ma J, Li D, Zhu X J Gastrointest Oncol. 2024; 15(1):415-424.

PMID: 38482224 PMC: 10932677. DOI: 10.21037/jgo-23-983.


Effect of PIVKA-II and AFP secretion status on early recurrence of hepatocellular carcinoma after open and laparoscopic surgery.

Cai Y, Xie K, Adeeb Alhmoud M, Lan T, Wan H, Hu D Cancer Med. 2023; 12(17):17866-17877.

PMID: 37596739 PMC: 10523999. DOI: 10.1002/cam4.6422.


Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study.

Huang J, Li L, Liu F, Tan B, Yang Y, Jiang B J Hepatocell Carcinoma. 2023; 10:573-586.

PMID: 37056420 PMC: 10086221. DOI: 10.2147/JHC.S404895.


References
1.
Hidaka M, Eguchi S, Okudaira S, Takatsuki M, Tokai H, Soyama A . Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver. Hepatol Res. 2008; 39(2):143-8. DOI: 10.1111/j.1872-034X.2008.00443.x. View

2.
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334(11):693-9. DOI: 10.1056/NEJM199603143341104. View

3.
Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A . Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993; 218(2):145-51. PMC: 1242923. DOI: 10.1097/00000658-199308000-00005. View

4.
Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S . The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol. 2007; 95(3):235-40. DOI: 10.1002/jso.20655. View

5.
Yao F, Ferrell L, Bass N, Bacchetti P, Ascher N, Roberts J . Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002; 8(9):765-74. DOI: 10.1053/jlts.2002.34892. View